PAHC - Company ID 0001069899
The table below shows PHIBRO ANIMAL HEALTH CORP's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|
| Revenue | $383.54M | $373.91M | $363.89M | $347.82M | $309.26M | $260.43M |
| Cost of revenue | $257.87M | $241.25M | $244.11M | $243.26M | $207.39M | $176.94M |
| Gross profit | $125.67M | $132.66M | $119.78M | $104.57M | $101.87M | $83.50M |
| R&D | - | - | - | - | - | - |
PHIBRO ANIMAL HEALTH CORP reported annual revenue of $1.30B for fiscal year 2025. That is up 27.4% from $1.02B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $751.53M (FY 2016) to $1.30B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $81.02M | $82.33M | $68.52M | $71.05M | $76.34M | $65.80M |
| Operating income | $44.65M | $50.33M | $51.26M | $33.52M | $25.53M | $17.70M |
| Income tax | $8.29M | $8.97M | $9.74M | $8.81M | $1.65M | $2.65M |
| Net income | $24.02M | $27.46M | $26.53M | $20.88M | $3.19M | $6.97M |
| EPS (diluted) | $0.59 | $0.67 | $0.65 | $0.51 | $0.08 | $0.17 |